-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 M48pzqbm7xCTLDSvDjCH2f6vyZv8tT4+fuzb7oYLnI7uID/etKjzF8l9gpRVdWXG
 LVlTiQungfmNqxGFCOu8pg==

<SEC-DOCUMENT>0000950157-05-000289.txt : 20050311
<SEC-HEADER>0000950157-05-000289.hdr.sgml : 20050311
<ACCEPTANCE-DATETIME>20050311145058
ACCESSION NUMBER:		0000950157-05-000289
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20050303
FILED AS OF DATE:		20050311
DATE AS OF CHANGE:		20050311

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			JOHNSON & JOHNSON
		CENTRAL INDEX KEY:			0000200406
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			0103

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-28748
		FILM NUMBER:		05675177

	BUSINESS ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
		BUSINESS PHONE:		7325242454

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CLOSURE MEDICAL CORP
		CENTRAL INDEX KEY:			0001016006
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				561959623
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		5250 GREENS DAIRY RD
		CITY:			RALEIGH
		STATE:			NC
		ZIP:			27616
		BUSINESS PHONE:		9198767800

	MAIL ADDRESS:	
		STREET 1:		5250 GREENS DAIRY RD
		CITY:			RALEIGH
		STATE:			NC
		ZIP:			27604

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRI POINT MEDICAL CORP
		DATE OF NAME CHANGE:	19960604
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2005-03-03</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001016006</issuerCik>
        <issuerName>CLOSURE MEDICAL CORP</issuerName>
        <issuerTradingSymbol>CLSR</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0000200406</rptOwnerCik>
            <rptOwnerName>JOHNSON &amp; JOHNSON</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1></rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity></rptOwnerCity>
            <rptOwnerState></rptOwnerState>
            <rptOwnerZipCode></rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock, par value $0.01 per share</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>5055948</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See explanatory note below.</value>
                    <footnoteId id="F1"/>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">Johnson &amp; Johnson, a New Jersey Corporation, is party to a Stockholder Agreement dated as of March 3, 2005 with certain stockholders of Closure Medical Corporation (the &quot;Stockholder Agreement).  Pursuant to the Stockholder Agreement, Johnson &amp; Johnson may be deemed a beneficial owner pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended (the &quot;Act&quot;), of 5,055,948 shares of common stock, par value $0.01 per share, of Closure Medical Corporation that are subject to the Stockholder Agreement (the &quot;Shares&quot;).  Pursuant to Rule 16a-1(a)(4) under the Act, Johnson &amp; Johnson hereby states that this Initial Statement of Beneficial Ownership of Securities on Form 3 shall not be deemed an admission that Johnson &amp; Johnson is, for purposes of Section 16 of the Act or otherwise, the beneficial owner of any equity securities of Closure Medical Corporation.  Johnson &amp; Johnson has no pecuniary interest in the Shares.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>Michael H. Ullmann</signatureName>
        <signatureDate>2005-03-09</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----